The multicultural landscape of North America is changing. The visible minority population in the United States is expected to reach 50% by the year 2050.
Photodynamic therapy (PDT) is used in dermatology for the treatment of malignant and non-malignant cutaneous diseases. PDT utilizes a photosensitizing agent and visible light in the presence of oxygen to produce reactive oxygen species (ROS).
Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition that has a paucity of effective therapeutic options. In recent years, progress has been made in the understanding of HS pathophysiology which has led to the development of new therapeutic options.
There is often a sense of dread when a dermatologist receives a referral for skin picking or excoriations. Due to the nature of our practices, these referrals typically suggest a longer visit, a frustrated patient, and ultimately, a less-than-satisfying visit for all parties involved.
With a growing array of immunomodulatory and biologic therapies available for common and rare skin disorders, prescribing dermatologists increasingly need to be aware of the potential adverse effects of these medications.
Traction alopecia (TA) is a form of hair loss caused by repetitive tension and pulling of the hair. TA most commonly occurs in women of Afro-Caribbean descent with afro-textured hair due to the higher prevalence of high-tension hairstyles such as braids and weaves.
Atopic dermatitis (AD) is a chronic, pruritic, inflammatory, multidimensional-burden skin disease. It is associated with numerous comorbidities, which have been summarized in the literature previously.
Vitiligo is characterized by chronic depigmented patches due to selective loss of melanocytes. The estimated prevalence of vitiligo is about 0.5 to 2% worldwide and, in addition to its significant cosmetic effect, it may cause major psychological distress.
Psoriasis is a chronic immune-mediated inflammatory condition of the skin that affects 2-3% of the general population.
